Vaccines against bluetongue in Europe.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Comparative Immunology, Microbiology & Infectious Diseases

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/J.CIMID.2007.07.006PMID 17765305
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.

  2007cited by this paper
• Transient adverse effects of an attenuated bluetongue virus vaccine on the quality of ram semen

  2007cited by this paper
• High Throughput Detection of Bluetongue Virus by a New Real-Time Fluorogenic Reverse Transcription—Polymerase Chain Reaction: Application on Clinical Samples from Current Mediterranean Outbreaks

  2006cited by this paper
• Differentiation between field and vaccine strain of bluetongue virus serotype 16.

  2006cited by this paper
• Bluetongue in northern Europe

  2006influential reference
• Bluetongue: characterization of virus types by reverse transcription-polymerase chain reaction.

  2006cited by this paper
• Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae).

  2005cited by this paper
• Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.

  2005cited by this paper
• Field vaccination of cattle using a bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.

  2004influential reference
• The epidemiology and diagnosis of bluetongue with particular reference to Corsica.

  2004influential reference
• Virological and serological response of cattle following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.

  2004cited by this paper
• Vaccination of cattle using monovalent modified-live vaccine against bluetongue virus serotype 2: innocuity, immunogenicity and effect on pregnancy.

  2004cited by this paper
• Effects of vaccination against bluetongue on milk production and quality in cattle vaccinated with live-attenuated monovalent type 2 vaccine.

  2004cited by this paper
• Bluetongue in Italy: Part I.

  2004cited by this paper
• Bluetongue vaccination in Europe: the Italian experience.

  2004cited by this paper
• Effects of bivalent bluetongue virus serotypes 2 and 9 vaccine on reproductive performance of cattle: a case study in Calabria, Italy.

  2004cited by this paper
• Genetically engineered structure-based vaccine for bluetongue disease.

  2004cited by this paper
• Virological and serological response of sheep following field vaccination with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9.

  2004cited by this paper
• Vaccination in the control strategy of bluetongue in Italy.

  2004cited by this paper
• The use of vaccination in the control of bluetongue in southern Africa.

  2004cited by this paper
• The Use of Risk Assessment to Decide the Control Strategy for Bluetongue in Italian Ruminant Populations

  2004cited by this paper
• Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows.

  2004cited by this paper
• Risk analysis on the introduction into free territories of vaccinated animals from restricted zones.

  2004cited by this paper
• Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2.

  2004cited by this paper
• Field vaccination of sheep with bivalent modified-live vaccine against bluetongue virus serotypes 2 and 9: effect on milk production.

  2004influential reference
• Transmission potential of South African Culicoides species for live-attenuated bluetongue virus.

  2004cited by this paper
• Culicoides and the global epidemiology of bluetongue virus infection.

  2004cited by this paper
• Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2.

  2004cited by this paper
• Bluetongue virus replication, molecular and structural biology.

  2004cited by this paper
• Genetic diversity of bluetongue viruses in south east Asia.

  2004cited by this paper
• Serological response in cattle and sheep following infection or vaccination with bluetongue virus.

  2004cited by this paper
• Infectious diseases of livestock

  2004cited by this paper
• Genetic diversification of field strains of bluetongue virus.

  2004cited by this paper
• An experience from the Mediterranean islands in Europe

  2003cited by this paper
• Studies on the safety and immunogenicity of the South African bluetongue virus serotype 2 monovalent vaccine: specific detection of the vaccine strain genome by RT-PCR.

  2003cited by this paper
• Identification of bluetongue virus serotype 2 (Corsican strain) by reverse-transcriptase PCR reaction analysis of segment 2 of the genome

  2002cited by this paper
• Occurrence of Genetic Drift and Founder Effect during Quasispecies Evolution of the VP2 and NS3/NS3A Genes of Bluetongue Virus upon Passage between Sheep, Cattle, andCulicoides sonorensis

  2001cited by this paper
• Sequence comparison of the L2 and S10 genes of bluetongue viruses from the United States and the People's Republic of China.

  1999cited by this paper
• Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

  1997cited by this paper
• Vaccines for bluetongue.

  1996cited by this paper
• Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.

  1996cited by this paper
• Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

  1994cited by this paper
• The epidemiology of bluetongue.

  1994cited by this paper
• The pathogenesis and immunology of bluetongue virus infection of ruminants.

  1994cited by this paper
• Protective efficacy of virus-like particles for bluetongue disease.

  1992cited by this paper
• Recombinant virus vaccine for bluetongue disease in sheep

  1990cited by this paper
• Immunologic response of sheep to inactivated and virulent bluetongue virus.

  1985cited by this paper
• Orbivirus infection of the bovine fetus.

  1985cited by this paper

• Bluetongue in the Mediterranean Basin: An Overview of Recent Hotspots and Advances in Vaccine Technologies.

  2026cites this paper
• VACCINATION OF PRONGHORN ANTELOPE (ANTILOCAPRA AMERICANA PENINSULARIS) WITH AN INACTIVATED BLUETONGUE VIRUS VACCINE ELICITS VIRUS-NEUTRALIZING ANTIBODY RESPONSE AND POSSIBLE PROTECTION UNDER FIELD CONDITIONS

  2026cites this paper
• Structure-Guided Engineering of Protein VP2 from Epizootic Hemorrhagic Disease Virus Maximizes Production and Confers Complete Protection as Subunit Vaccine

  2025cites this paper
• Evaluating the effect of vaccination on the impact of BTV-3 in Dutch sheep flocks in 2024.

  2025cites this paper
• Rapid Quantification of Bluetongue Virus-Neutralizing Antibodies Using Bioluminescent Reporter-Expressing Viruses

  2025cites this paper
• Semen Quality in Rams Is Severely but Temporarily Affected by Bluetongue Virus Serotype 3 Infection

  2025cites this paper
• Novel multiplex Magpix assay platforms for simultaneous detection of different serotypes of BTV circulating in India

  2025cites this paper
• Safety and Efficacy of Plant‐Produced Trivalent Virus‐Like Particle Vaccine Candidate Against Bluetongue Disease

  2025cites this paper
• Linking vector favourable environmental conditions with serological evidence of widespread bluetongue virus exposure in livestock in Ecuador

  2025cites this paper
• Potential mechanisms underlying bluetongue virus emergence and spread

  2024cites this paper
• Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus

  2024cites this paper
• Development and Evaluation of a Candidate Inactivated Vaccine Against Bluetongue Virus Serotype 4 (BTV4)

  2024cites this paper
• The Global Burden of Emerging and Re-Emerging Orbiviruses in Livestock: An Emphasis on Bluetongue Virus and Epizootic Hemorrhagic Disease Virus

  2024influential citation
• Efficacy of an inactivated EHDV-8 vaccine in preventing viraemia and clinical signs in experimentally infected cattle

  2024cites this paper
• Virus Neutralization Test for Detecting and Quantifying Serum-Neutralizing Antibodies to Epizootic Hemorrhagic Disease Virus (EHDV) (Serotypes 1, 2, and 4-8).

  2024cites this paper
• Vector-Borne Viral Diseases as a Current Threat for Human and Animal Health—One Health Perspective

  2022cites this paper
• Serological Responses in Cattle following Booster Vaccination against Serotypes 4 and 8 Bluetongue Virus with Two Bivalent Commercial Inactivated Vaccines

  2022cites this paper
• Pentavalent Disabled Infectious Single Animal (DISA)/DIVA Vaccine Provides Protection in Sheep and Cattle against Different Serotypes of Bluetongue Virus

  2021cites this paper
• Next-generation tools to control biting midge populations and reduce pathogen transmission

  2021cites this paper
• A Duplex Fluorescent Microsphere Immunoassay for Detection of Bluetongue and Epizootic Hemorrhagic Disease Virus Antibodies in Cattle Sera

  2021cites this paper
• Overview of Slovenian Control Programmes for Cattle Diseases Not Regulated by the European Union

  2021cites this paper
• Identification of a novel bluetongue virus 1 specific B cell epitope using monoclonal antibodies against the VP2 protein.

  2021cites this paper
• Overview of Slovenian Control Programmes for Selected Cattle Diseases, Listed Under Category C, D or E of the European Animal Health Law

  2021cites this paper
• High dispersal capacity of Culicoides obsoletus (Diptera: Ceratopogonidae), vector of bluetongue and Schmallenberg viruses, revealed by landscape genetic analyses

  2021cites this paper
• Safety and efficacy of a Bluetongue inactivated vaccine (serotypes 1 and 4) in sheep.

  2021cites this paper
• Development of an inactivated combined vaccine for protection of cattle against lumpy skin disease and bluetongue viruses.

  2021cites this paper
• High dispersal capacity of Culicoides obsoletus (Diptera: Ceratopogonidae), vector of bluetongue and Schmallenberg viruses, revealed by landscape genetic analyses

  2021cites this paper
• Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.

  2020cites this paper
• An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India

  2020influential citation
• A protective bivalent vaccine against Rift Valley fever and bluetongue

  2020cites this paper
• Bluetongue virus viral protein 7 stability in the presence of glycerol and sodium chloride

  2020cites this paper
• Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

  2020cites this paper
• Alternative methods to reduce the animal use in quality controls of inactivated BTV8 Bluetongue vaccines.

  2020cites this paper
• Important Dispersal Capacity of One Main Species Vector of Bluetongue and Schmallenberg Viruses Culicoides Obsoletus (Diptera: Ceratopogonidae) Revealed by Landscape Genetic Analyses 

  2020cites this paper
• The tree that hides the forest: cryptic diversity and phylogenetic relationships in the Palaearctic vector Obsoletus/Scoticus Complex (Diptera: Ceratopogonidae) at the European level

  2020cites this paper
• A protective bivalent vaccine against Rift Valley fever and bluetongue

  2020cites this paper
• Viral Vector Vaccines against Bluetongue Virus

  2020cites this paper
• Comparative Evaluation of T-Cell Immune Response to BTV Infection in Sheep Vaccinated with Pentavalent BTV Vaccine When Compared to Un-Vaccinated Animals

  2019cites this paper
• Vector Competence of Italian Populations of Culicoides for Some Bluetongue Virus Strains Responsible for Recent Northern African and European Outbreaks

  2019cites this paper
• Specific Infectious Diseases Causing Infertility and Subfertility in Cattle

  2019cites this paper
• Bluetongue Disease

  2019cites this paper
• Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only.

  2019cites this paper
• Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle

  2019influential citation
• Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.

  2019cites this paper
• Dynamique des populations de Culicoides à l’île de La Réunion, moucherons vecteurs d’orbiviroses

  2019cites this paper
• Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines

  2019cites this paper
• Mosquitoes, midges and microbiota: European vector diversity and the spread of pathogens

  2019cites this paper
• Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice

  2019cites this paper
• Prospects of Next-Generation Vaccines for Bluetongue

  2019cites this paper
• Comparative laboratory and field study of biorational insecticides for Culicoides biting midge management in larval developmental sites.

  2019cites this paper
• Seroprevalence of bluetongue disease virus (BTV) among domestic ruminants in Kosovo and first record of BTV serotype 4 in sheep.

  2019cites this paper
• Investigation of Seroprevalence of Bluetongue Diseases in Sheep in the Province of Siirt

  2019cites this paper
• Transboundary Animal Diseases in Sahelian Africa and Connected Regions

  2019cites this paper
• Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR (cid:1) / (cid:1) mice

  2019cites this paper
• New generation vaccines against bluetongue virus

  2018influential citation
• Some adverse events following immunization in veterinary medicine

  2018influential citation
• Reassortment of bluetongue virus vaccine serotypes in cattle

  2018cites this paper
• WITHDRAWN: Cognition and behavior in sheep repetitively inoculated with aluminum adjuvant-containing vaccines or aluminum adjuvant only.

  2018cites this paper
• Isolation and molecular characterization of bluetongue virus from Southern India

  2018cites this paper
• A

  2018cites this paper
• Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.

  2018cites this paper
• Bluetongue: a review

  2018influential citation
• Isolation and evolutionary analysis of Australasian topotype of bluetongue virus serotype 4 from India.

  2018cites this paper
• Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.

  2018cites this paper
• Solubilisation and purification of recombinant bluetongue virus VP7 expressed in a bacterial system.

  2018cites this paper
• Bluetongue in Europe and Romania in the last years

  2018cites this paper
• Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions

  2018cites this paper
• New Approaches for Improvement of Diva Vaccines and Their Companion Diagnostic Tests for Foot-and-Mouth Disease and Bluetongue Disease

  2018cites this paper
• Bluetongue: Aetiology, Epidemiology, Pathogenesis, Diagnosis and Control

  2017cites this paper
• Development of plant-produced protein body vaccine candidates for bluetongue virus

  2017cites this paper
• A review of potential bluetongue virus vaccine strategies.

  2017cites this paper
• Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations

  2017influential citation
• Efficacy of vaccination for bluetongue virus serotype 8 performed shortly before challenge and implications for animal trade.

  2017cites this paper
• Desarrollo de vacunas recombinantes marcadoras multiserotipo frente al virus de la lengua azul

  2017influential citation
• Bluetongue Virus: From BTV-1 to BTV-27.

  2017cites this paper
• Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): bluetongue

  2017influential citation
• Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.

  2017cites this paper
• Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): avian mycoplasmosis (Mycoplasma gallisepticum, M. meleagridis)

  2017influential citation
• Effect of Viral Antigen Levels on the Serological Response and Efficiency of the Binary Ethylenimine-Inactivated Bluetongue Virus Serotype-16 Vaccine

  2016cites this paper
• Assessing the potential for Bluetongue virus 8 to spread and vaccination strategies in Scotland

  2016cites this paper
• Humoral Immune Response and Protective Efficacy of Binary Ethylenimine (BEI) Inactivated Pentavalent Bluetongue Vaccine after Challenge with Homologous Virus in Sheep

  2016cites this paper
• Epidemiology of Bluetongue in India.

  2016influential citation
• ISWミデキaキI;デキラミ ラa C;デデノWどDWヴキ┗WS Vラノ;デキノWゲ デエ;デ MラS┌ノ;デW デエW BWエ;┗キラヴ;ノ RWゲヮラミゲW ラa デエW Bキデキミェ MキSェW C┌ノキIラキSWゲ ミ┌HWI┌ノラゲ┌ゲ

  2016cites this paper
• Factors Affecting Seroconversion Rates in Cattle Vaccinated with Two Commercial Inactivated BTV-8 Vaccines Under Field Conditions.

  2016cites this paper
• Temporal modelling of disease outbreaks using state space and delay differential equations

  2016cites this paper
• Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.

  2016cites this paper
• Evaluation of Humoral Response and Protective Efficacy of an Inactivated Vaccine Against Peste des Petits Ruminants Virus in Goats.

  2016cites this paper
• An ex-ante economic appraisal of Bluetongue virus incursions and control strategies

  2015cites this paper
• DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1

  2015influential citation
• Bluetongue Virus in wild ruminants in Europe: Concerns and facts, with a brief reference to bluetongue in cervids in Greece during the 2014 outbreak ☆

  2015cites this paper
• Prevalence of Bluetongue Virus Antibodies and Associated Risk Factors Among Cattle in East Darfur State, Sudan

  2015cites this paper
• Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses

  2015cites this paper
• Integrated fly management in European ruminant operations from the perspective of directive 2009/128/EC on sustainable use of pesticides

  2015influential citation
• The effect of Rift Valley fever virus Clone 13 vaccine on semen quality in rams

  2015cites this paper
• Bluetongue: Indian perspective.

  2015cites this paper
• An experimental subunit vaccine based on Bluetongue virus 4 VP2 protein fused to an antigen-presenting cells single chain antibody elicits cellular and humoral immune responses in cattle, guinea pigs and IFNAR(-/-) mice.

  2015cites this paper
• Full-Genome Sequencing of Four Bluetongue Virus Serotype 11 Viruses.

  2015cites this paper
• Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.

  2015cites this paper
• Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.

  2015cites this paper
• La vaccination dans la gestion des maladies vectorielles : rôles et réponses de l’industrie du médicament vétérinaire

  2015cites this paper